Can You Stop Mounjaro After Losing Weight?

What clinical trials tell us about stopping tirzepatide

The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that adults taking tirzepatide at 15mg lost an average of roughly 20–21% of their body weight over 72 weeks — a result unmatched by any single-agonist medicine in that period. But the trial also demonstrated something less discussed in headlines: much of the biology driving that loss depends on the medicine being active.

Tirzepatide acts on two gut-hormone receptors (GIP and GLP-1) that regulate appetite, fullness and gastric emptying. Stop the medicine and those receptor signals return to their pre-treatment baseline. Hunger comes back, often within a fortnight of the last injection. Gastric emptying speeds up. Portion tolerance changes. None of this is failure — it is physiology.

The SURMOUNT extension data, alongside semaglutide discontinuation studies, consistently show that people who stop without a structured lifestyle and support plan regain a substantial proportion of lost weight within 12 months. The degree of regain varies considerably between individuals depending on how embedded their new habits are, starting weight, metabolic health and other factors. You can read more about how weight loss progresses on Mounjaro to understand what the medicine is doing across a full course of treatment.

Why stopping feels like going backwards (and the misconception worth clearing up)

There is a persistent idea that if you have already lost the weight, the medicine has "done its job" and you no longer need it, similar to finishing a course of antibiotics. It is an understandable instinct. But tirzepatide is not treating a temporary infection; it is managing a chronic biological condition in which the body's weight-regulation system continues to push back toward a higher set point. The moment the medicine is withdrawn, that push resumes.

That does not mean stopping is always wrong. Some people reach a weight that feels sustainable, have built robust habits around eating and activity, and make an informed choice, with their prescriber, to discontinue and monitor carefully. Others find their health markers have improved enough that the risk-benefit calculation shifts. If you are wondering when weight loss typically levels off on Mounjaro, the pattern matters here: people who stop during a plateau are in a different position from those stopping after reaching a stable, healthy weight.

What the evidence does not support is stopping abruptly without a plan and expecting the results to hold passively. A prescriber at our clinical team works through this with patients, not to push continuation for its own sake, but because the data genuinely inform the conversation.

What happens in practice when you stop, and how to protect what you have gained

In the weeks after the last injection, the most consistent reports are increased hunger and a reduced sense of fullness at meals. For some people this is mild and manageable; for others it is abrupt enough to unsettle the eating patterns they built during treatment. Neither experience means anything went wrong. It is worth reading what to do if weight loss has already slowed before making any changes, because the dynamics of late-treatment plateaus and post-treatment regain overlap in ways that affect the decision.

The NHS patient information for tirzepatide advises following the reduced-calorie diet and activity programme that accompanies treatment throughout and after. Practically, the habits that carry the most weight are protein adequacy at each meal (which prolongs satiety independently of the medicine), consistent resistance or strength activity, and regular self-monitoring of weight without panic. People who have established those habits during treatment tend to regain less than those who relied primarily on the appetite suppression.

Concerns about regain after stopping are common enough that a separate question addresses how to minimise weight gain after finishing Mounjaro, worth reading alongside this one. Some people also notice unexpectedly continued loss immediately post-treatment, which is covered in detail at why weight sometimes keeps dropping after stopping Mounjaro.

Having the stopping conversation with your prescriber

No one should stop a prescription medicine because a website said the evidence leans a certain way. The right process is a clinical review: your prescriber looks at your current weight, the trajectory over the last few months, your blood pressure and any other relevant markers, your diet and activity picture, and your own view of how manageable life feels without the medicine. The conclusion might be to stop confidently, to step down to a lower maintenance dose, or to continue at the current dose for a defined further period.

At our Mounjaro service, every repeat order involves exactly this kind of clinical re-review, not a rubber stamp. If you are considering stopping and want to talk it through before making the call, a free consultation with our prescribers is a straightforward starting point. They can also advise on the broader landscape of weight management options if you are thinking about what comes next.